Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-19-000082

Options or other derivatives

  • Chief Medical Officer acquired 350,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schecter Alison D. · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-07-15 Grant or award : show line 1 in the form Common Stock +350,000 $1.71 2029-07-14 350,000 350,000 D
Loading xslF345X03/wf-form4_156339467597510.xml…